Drug Channels Archive for July, 2019

Click a link below to view the mailing archive as if it had been sent to you.

2019-07-30 07:35Drug Channels News Roundup, July 2019: Amazon/PillPack, Novo Nordisk on the G2N Bubble, Copay Accumulators, and Adam's Favorite Chart
2019-07-29 07:34Drug Channels - CBI's 5th Annual Life Sciences Compliance Congress for Specialty Products
2019-07-26 07:37Drug Channels - Improving Medication Access Through Network Connections to Impact More Patients
2019-07-23 07:33Drug Channels - Our STAT Op-Ed: Drug Importation Can't Coexist with U.S. Track-and-Trace Law
2019-07-22 07:38Drug Channels - CBI's 13th Hub and SPP Model Optimization
2019-07-19 07:37Drug Channels - Expanding Patient Engagement in Commercial Healthcare
2019-07-18 07:37Drug Channels - Walgreens, CVS, and Walmart Lead the 25,000 Pharmacies Now Profiting From the 340B Program
2019-07-16 07:07Drug Channels - JAMA: Withdraw This Flawed and Inaccurate Article About the 340B Program and Drug Prices
2019-07-15 07:34Drug Channels - CBI's 3rd Annual Finance & Account for Bioscience Companies
2019-07-12 07:51Drug Channels - Six Reasons Why the Rebate Rule Failed—And What's Next
2019-07-11 07:33Drug Channels - The Gross-to-Net Bubble Reached a Record $166 Billion in 2018 (rerun)
2019-07-10 07:40Drug Channels - How Health Plans Profit—and Patients Lose—From Highly-Rebated Brand-Name Drugs (rerun)
2019-07-09 07:23Drug Channels - The Big Three Generic Drug Mega-Buyers Drove Double-Digit Deflation in 2018. Stability ahead? (rerun)
2019-07-08 07:35Drug Channels - PBMI's 2019 Specialty Rx Forum
2019-07-01 07:34Drug Channels - National Association of Specialty Pharmacy 7th Annual Meeting and Expo


<< Archive IndexSubscribe >>